DECEMBER - 20225LAST WORDC O NT E NT SCarlos Pedraza, PhD, Director of CNS Biology, AlkermesCOVID-19 as a Catalyst for Digital Transformation of Clinical Research:Are We There Yet?Dr. Ammar Raza, Regional Medical Director- Middle East and Africa, Allergan Aesthetics, AbbVie16Machine-Learning-Generated Insights from Health Data: Promise of Natural Language ProcessingKim Wager, Scientific Director, Oxford PharmaGenesis24New Innovative Probiotics Reduces Risk of Aspirin-Induced UlcersAnders Damholt, PhD Biochemistry, Head of Clinical Development Human Health Innovation, Chr. Hansen18Pharmaceutical Tablet Coating ­ Past, Present and FutureSteve Brown, Senior Director EU and APAC Global Manufacturing Science and Technology, Teva Pharmaceuticals [NYSE:TEVA]26An Open Innovation Approach Applied to the Pharmaceutical IndustryFederico Piutti, Innovation Manager, Bormioli Pharma19Real-Life Computer Vision in Manufacturing: All the Things Academy Doesn't Teach YouGuglielmo Iozzia, Associate Director, Business Tech Analysis, MSD Pharmaceuticals22Challenges and Opportunities for AI in Drug DiscoveryBobby Prill, Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Research Institute, Inc. and Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring Research Institute, Inc.20Innovation vs Validation in Early Drug DiscoveryCXO INSIGHTS30
< Page 4 | Page 6 >